Literature DB >> 8602353

Oligonucleotide facilitators may inhibit or activate a hammerhead ribozyme.

E Jankowsky1, B Schwenzer.   

Abstract

Facilitators are oligonucleotides capable of affecting hammerhead ribozyme activity by interacting with the substrate at the termini of the ribozyme. Facilitator effects were determined in vitro using a system consisting of a ribozyme with 7 nucleotides in every stem sequence and two substrates with inverted facilitator binding sequences. The effects of 9mer and 12mer RNA as well as DNA facilitators which bind either adjacent to the 3'- or 5'-end of the ribozyme were investigated. A kinetic model was developed which allows determination of the apparent dissociation constant of the ribozyme-substrate complex from single turnover reactions. We observed a decreased dissociation constant of the ribozyme-substrate complex due to facilitator addition corresponding to an additional stabilization energy of delta delta G=-1.7 kcal/mol with 3'-end facilitators. The cleavage rate constant was increased by 3'-end facilitators and decreased by 5'-end facilitators. Values for Km were slightly lowered by all facilitators and kcat was increased by 3'-end facilitators and decreased by 5'-end facilitators in our system. Generally the facilitator effects increased with the length of the facilitators and RNA provided greater effects than DNA of the same sequence. Results suggest facilitator influences on several steps of the hammerhead reaction, substrate association, cleavage and dissociation of products. Moreover, these effects are dependent in different manners on ribozyme and substrate concentration. This leads to the conclusion that there is a concentration dependence whether activation or inhibition is caused by facilitators. Conclusions are drawn with regard to the design of hammerhead ribozyme facilitator systems.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8602353      PMCID: PMC145664          DOI: 10.1093/nar/24.3.423

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  28 in total

1.  Enhancement of ribozyme catalytic activity by a contiguous oligodeoxynucleotide (facilitator) and by 2'-O-methylation.

Authors:  J Goodchild
Journal:  Nucleic Acids Res       Date:  1992-09-11       Impact factor: 16.971

2.  Chimeric DNA-RNA hammerhead ribozymes have enhanced in vitro catalytic efficiency and increased stability in vivo.

Authors:  N R Taylor; B E Kaplan; P Swiderski; H Li; J J Rossi
Journal:  Nucleic Acids Res       Date:  1992-09-11       Impact factor: 16.971

3.  Substrate sequence effects on "hammerhead" RNA catalytic efficiency.

Authors:  M J Fedor; O C Uhlenbeck
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

4.  Implications of ribozyme kinetics for targeting the cleavage of specific RNA molecules in vivo: more isn't always better.

Authors:  D Herschlag
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

5.  Ribozymes that cleave an RNA sequence from human immunodeficiency virus: the effect of flanking sequence on rate.

Authors:  J Goodchild; V Kohli
Journal:  Arch Biochem Biophys       Date:  1991-02-01       Impact factor: 4.013

6.  Use of EDTA derivatization to characterize interactions between oligodeoxyribonucleoside methylphosphonates and nucleic acids.

Authors:  S B Lin; K R Blake; P S Miller; P O Ts'o
Journal:  Biochemistry       Date:  1989-02-07       Impact factor: 3.162

7.  Role of divalent metal ions in the hammerhead RNA cleavage reaction.

Authors:  S C Dahm; O C Uhlenbeck
Journal:  Biochemistry       Date:  1991-10-01       Impact factor: 3.162

8.  Sequence requirements of the hammerhead RNA self-cleavage reaction.

Authors:  D E Ruffner; G D Stormo; O C Uhlenbeck
Journal:  Biochemistry       Date:  1990-11-27       Impact factor: 3.162

9.  Hammerhead ribozyme-mediated cleavage of the long terminal repeat RNA of human immunodeficiency virus type 1.

Authors:  O Heidenreich; F Eckstein
Journal:  J Biol Chem       Date:  1992-01-25       Impact factor: 5.157

10.  Facilitation of hammerhead ribozyme catalysis by the nucleocapsid protein of HIV-1 and the heterogeneous nuclear ribonucleoprotein A1.

Authors:  E L Bertrand; J J Rossi
Journal:  EMBO J       Date:  1994-06-15       Impact factor: 11.598

View more
  5 in total

1.  New modalities in oncology: ribozymes.

Authors:  C Casey Cunningham
Journal:  Proc (Bayl Univ Med Cent)       Date:  2002-07

Review 2.  Hammerhead ribozyme kinetics.

Authors:  T K Stage-Zimmermann; O C Uhlenbeck
Journal:  RNA       Date:  1998-08       Impact factor: 4.942

3.  Peptide nucleic acid (PNA) is capable of enhancing hammerhead ribozyme activity with long but not with short RNA substrates.

Authors:  E Jankowsky; G Strunk; B Schwenzer
Journal:  Nucleic Acids Res       Date:  1997-07-15       Impact factor: 16.971

4.  Target-dependent on/off switch increases ribozyme fidelity.

Authors:  Lucien Junior Bergeron; Jean-Pierre Perreault
Journal:  Nucleic Acids Res       Date:  2005-02-24       Impact factor: 16.971

Review 5.  Modulating RNA structure and catalysis: lessons from small cleaving ribozymes.

Authors:  Cedric Reymond; Jean-Denis Beaudoin; Jean-Pierre Perreault
Journal:  Cell Mol Life Sci       Date:  2009-08-30       Impact factor: 9.261

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.